EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikaz 1.401 - 1.450 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride	218-130-3	2051-79-8	Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1		Details
N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine	426-150-0	121246-28-4	Skin Sens. 1		Details
N-{2-[[1,1'-bi (cyclopropyl)]-2-yl] phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxane	688-331-2	874967-67-6	Carc. 2		Details
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine	431-060-1	153719-38-1	Acute Tox. 4; Skin Sens. 1		Details
N-methylformamide	204-624-6	123-39-7	Repr. 1B; Acute Tox. 4		Details
N-methylbenzene-1,2-diammonium hydrogen phosphate	424-460-0	283167-56-6	Acute Tox. 4; Skin Sens. 1		Details
N-methylaniline	202-870-9	100-61-8	Acute Tox. 3; STOT RE 2		Details
N-methylacetamide	201-182-6	79-16-3	Repr. 1B	R Toxic for reproduction (article 57c)	Details
N-methyl-p-toluidine	210-769-6	623-08-5	Acute Tox. 3; STOT RE 2		Details
N-methyl-o-toluidine	210-260-9	611-21-2	Acute Tox. 3; STOT RE 2		Details
N-methyl-N-cyanomethylmorpholiniummethylsulfate	429-340-1	186295-11-4	Acute Tox. 4; Eye Dam. 1		Details
N-methyl-N-2,4,6-tetranitroaniline; tetryl	207-531-9	479-45-8	Expl. 1.1; Acute Tox. 3; STOT RE 2		Details
N-methyl-m-toluidine	211-795-0	696-44-6	Acute Tox. 3; STOT RE 2		Details
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate N-METHYL-4-(P-FORMYLSTYRYL)-PYRIDINIUM METHYLSULFATE; SBQ; SBQ-SALZ	418-240-3	74401-04-0	Skin Sens. 1		Details
N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone	212-828-1	872-50-4	Repr. 1B; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2	R Toxic for reproduction (article 57c)	Details
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2		Details
N-isopropyl-N'-phenyl-p-phenylenediamine	202-969-7	101-72-4	Acute Tox. 4; Skin Sens. 1		Details
n-hexyllithium N-HEXYLLITHIUM	404-950-0	21369-64-2	Water-react. 1; Pyr. Sol. 1; Skin Corr. 1A		Details
n-hexane	203-777-6	110-54-3	Flam. Liq. 2; Repr. 2; Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; STOT SE 3		Details
N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide DTBA	401-980-6	-	Skin Irrit. 2; Skin Sens. 1		Details
N-ethylaniline	203-135-5	103-69-5	Acute Tox. 3; STOT RE 2		Details
N-ethyl-N-methylpiperidinium iodide CATALYST 4017	407-780-5	4186-71-4	Acute Tox. 4		Details
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine	437-720-3	227085-51-0	Eye Dam. 1		Details
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one	220-250-6	2687-91-4	Repr. 1B		Details
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate DIMETHYLPAPAMIDOLAURDIMONIUM TOSYLATE	421-130-8	156679-41-3	Eye Dam. 1; Skin Sens. 1		Details
N-cyclohexylbenzothiazole-2- sulphenamide	202-411-2	95-33-0	Skin Sens. 1		Details
N-cyclohexyl-S, S-dioxo; benzo[b]tiophene-2-carboxamide PREVENTOL VP OC 3061	423-990-1	149118-66-1	Acute Tox. 4; Eye Dam. 1		Details
N-carboxymethyliminobis(ethylenenitrilo)tetra (acetic acid)	200-652-8	67-43-6	Repr. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2		Details
n-butyronitrile	203-700-6	109-74-0	Flam. Liq. 2; Acute Tox. 3		Details
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide DISPERSOL YELLOW XF	407-970-8	75511-91-0	Skin Sens. 1		Details
N-butyl-2-(4-morpholinylcarbonyl)benzamide EP 389	407-730-2	104958-67-0	Eye Irrit. 2; Skin Sens. 1		Details
n-butyl propionate	209-669-5	590-01-2	Flam. Liq. 3		Details
n-butyl methacrylate	202-615-1	97-88-1	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1		Details
n-butyl acrylate	205-480-7	141-32-2	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1		Details
n-butyl acetate	204-658-1	123-86-4	Flam. Liq. 3; STOT SE 3		Details
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine	425-300-2	186450-73-7	Skin Sens. 1		Details
N-amidino-N-methylglycine-2-oxopropionate	429-120-5	208535-04-0	Eye Dam. 1		Details
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide	424-550-1	84245-12-5	Carc. 1B; Muta. 1B; Repr. 1B		Details
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide	427-880-2	90357-53-2	STOT RE 2		Details
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide BENZANILID-DISPERSE-INTERMEDIATE ZP 9955	411-590-8	70693-57-1	Skin Corr. 1B		Details
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4		Details
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate DS 100	415-060-7	1379678-87-1	Eye Dam. 1; Skin Sens. 1		Details
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919	416-860-9	777891-21-1	Repr. 2; Skin Sens. 1		Details
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride	430-360-8	84793-24-8	Eye Dam. 1; Skin Sens. 1		Details
N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide BTAD	416-470-9	170292-97-4	Eye Irrit. 2		Details
N-2-naphthylaniline; N-phenyl-2-naphthylamine	205-223-9	135-88-6	Carc. 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1		Details
N-(n-octyl)-2-pyrrolidone NOP; SURFADONE LP-100 SURFACTANT	403-700-8	2687-94-7	Skin Corr. 1B		Details
N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]	213-103-2	924-42-5	Carc. 1B; Muta. 1B; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b)	Details
N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide	211-952-3	719-96-0	Skin Irrit. 2		Details
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide TSD-40	413-200-1	129604-78-0	Skin Sens. 1		Details

Prikaz 1.401 - 1.450 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items